Inventor · disambiguated record
Noah Laban Rosenberg
Also filed as: ROSENBERG NOAH LABAN
3 granted patents·4 pending applications·4 citations·filing 2016–2024
61Inventor score
Files withESPERION THERAPEUTICS INC7
Top patents by PatentIndex Score
7 records- 0182US11744816B2Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2020·Granted Sep 5, 2023·1 cites·8 claims
- 0282US11116739B2Fixed dose combinations and formulations comprising ETC1002 and one or more statins and methods of treating or reducing cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2016·Granted Sep 14, 2021·2 cites·1 claims
- 0380US2025064767A1Fixed dose combinations and formulations comprising etc1002 and one or more statins and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0476US2024148681A1Fixed dose combinations and formulations comprising etc1002 and one or more statins and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0575US2024398746A1Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0669US10912751B2Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2016·Granted Feb 9, 2021·1 cites·13 claims
- 0768US2022110904A1Fixed dose combinations and formulations comprising etc1002 and one or more statins and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Noah Laban Rosenberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →